Get the app!
Back to Trades

Bisson Sabine

CHIEF OPERATING OFFICERCIK 0002152874

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Bisson Sabine, CHIEF OPERATING OFFICER, has filed 2 SEC reports (2026), all concentrated in Retension Pharmaceuticals, Inc. (RTSN), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Oct 13RTSN
Retension Pharmaceuticals, Inc.
Bisson SabineCHIEF OPERATING OFFICERConversion$0
Oct 8RTSN
Retension Pharmaceuticals, Inc.
Bisson SabineChief Operating OfficerOther$0

2 filings